Live Breaking News & Updates on Acceleration Of Life Sciences
Stay updated with breaking news from Acceleration of life sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share: Q4 revenue of $189.7 million, up 9% year-over-year, and up 18% sequentially Q4 subscription-based platform revenue of $163.5 million, up 14% year-over-year and up 15% sequentially, equating to 86% of Q4 total revenue Q4 net income of $21.4 million, resulting in diluted net income of $0.14 per share Q4 Non-GAAP net income of $30.8 million, resulting in Non-GAAP diluted net income of $0.21 per share, up 40% year-over-year, and up 31% sequentially Q4 Adjusted EBITDA of $68.1 million, up 18% year-over-year, and up 16% sequentially Q4 Adjusted EBITDA margin of 35.9%, up 270 basis points year-over-year Q4 new sales ACV Full Year 2020 Highlights Full year subscription-based platform revenue of $585.1 million, up 10% year-over-year Full year net income of $22.6 million, resulting in diluted net income of $0.15 per share, up 200% year-over-year ....